Sara E. Schad
Impact in
- Immunology top 5%
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 2
- Phagocytosis and Immune Regulation 2
- Immune Cell Function and Interaction 2
- Oncology 5
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Ruben D. Carrasco (1 shared paper)Roderick Terry Bronson (1 shared paper)Scott P. Davis (1 shared paper)Mercedes Lobera (1 shared paper)Michael A. Nolan (1 shared paper)Alaba O. Sotayo (1 shared paper)Anthony G. Letai (1 shared paper)Shawn F. Johnson (1 shared paper)
- Journals
- Nature (1 paper)Molecular and Cellular Endocrinology (1 paper)The Journal of Experimental Medicine (1 paper)Cell (1 paper)Cancer Cell (1 paper)
- Partner nations
- United StatesDenmarkIsrael
In The Last Decade
Sara E. Schad
9 papers receiving 970 citations
Sara E. Schad's Hit Papers
Peers
Comparison fields: 5 of 65
- Immunology 578
- Oncology 360
- Cancer Research 65
- Molecular Biology 305
- Biological Psychiatry 7
Countries citing papers authored by Sara E. Schad
This map shows the geographic impact of Sara E. Schad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara E. Schad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara E. Schad more than expected).
Fields of papers citing papers by Sara E. Schad
This network shows the impact of papers produced by Sara E. Schad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara E. Schad. The network helps show where Sara E. Schad may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara E. Schad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages Hit paper breakdown → | 2017 | 464 |
| 2 | T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants Hit paper breakdown → | 2023 | 226 |
| 3 | 2021 | 153 | |
| 4 | 2021 | 42 | |
| 5 | 2022 | 30 | |
| 6 | 2022 | 23 | |
| 7 | 2015 | 19 | |
| 8 | 2016 | 17 | |
| 9 | 2024 | 5 |
About Sara E. Schad
Sara E. Schad is a scholar working on Immunology, Oncology, Physiology, Genetics and Hematology, having authored 9 papers that have together received 979 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Phagocytosis and Immune Regulation (2 papers), Immune Cell Function and Interaction (2 papers), Multiple Myeloma Research and Treatments (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Immunology (578 citations), Oncology (360 citations), Cancer Research (65 citations), Molecular Biology (305 citations) and Biological Psychiatry (7 citations). Sara E. Schad has collaborated with scholars based in United States, Denmark and Israel. Frequent co-authors include Ruben D. Carrasco, Roderick Terry Bronson, Scott P. Davis, Mercedes Lobera, Michael A. Nolan, Alaba O. Sotayo, Anthony G. Letai, Shawn F. Johnson, Jennifer L. Guerriero and Suzan Lazo. Their work appears in journals such as Nature, Molecular and Cellular Endocrinology, The Journal of Experimental Medicine, Cell and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.